Similar articles

• FDA drug information that never reaches clinicians.

  Messerli FH, Bangalore S. Messerli FH, et al. N Engl J Med. 2010 Feb 11;362(6):562; author reply 563. N Engl J Med. 2010. PMID: 20175300 No abstract available.
• "Black box" warning: wake-up call or overreaction?

  Szefler SJ, Whelan GJ, Leung DY. Szefler SJ, et al. J Allergy Clin Immunol. 2006 Jan;117(1):26-9. doi: 10.1016/j.jaci.2005.11.006. J Allergy Clin Immunol. 2006. PMID: 16387579 No abstract available.
• Primum non nocere and "black box" warnings.

  Pearlman DS. Pearlman DS. J Allergy Clin Immunol. 2006 Jan;117(1):30-1. doi: 10.1016/j.jaci.2005.09.030. Epub 2005 Dec 2. J Allergy Clin Immunol. 2006. PMID: 16387580 No abstract available.
• Paediatric clinical trials: redressing the imbalance.

  Schreiner MS. Schreiner MS. Nat Rev Drug Discov. 2003 Dec;2(12):949-61. doi: 10.1038/nrd1253. Nat Rev Drug Discov. 2003. PMID: 14654794 Review. No abstract available.
• A needed technical fix?

  Robertson WO. Robertson WO. Vet Hum Toxicol. 2000 Apr;42(2):118-9. Vet Hum Toxicol. 2000. PMID: 10750184 Review. No abstract available.